Ambulatory screening and decontamination to prevent Staphylococcus aureus complications in patients undergoing elective surgery (STAUfrei): study protocol for a controlled intervention study

BMC Infect Dis. 2020 Jan 31;20(1):95. doi: 10.1186/s12879-020-4804-7.

Abstract

Background: Surgical site infections (SSI) are the most common health care associated infections in German acute hospitals and can result in prolonged hospital stays, increased use of antibiotics and utilisation of care. Staphylococcus aureus bacteria (methicillin-resistant S Aureus (MRSA) and methicillin-susceptible S Aureus (MSSA)) are amongst the most prominent causes of SSI. While up to 90% of documented S Aureus colonization is already detectable prior to hospital admission, the majority of hygiene measures in Germany is focused on the hospital setting. It is hypothesized that early detection and decontamination of S Aureus colonization in primary care can prevent health care associated infections and reduce the number of S Aureus isolates in the hospital setting.

Methods: This study is a controlled interventional study (N = 13,260) with a pre-post comparison. The intersectoral intervention (over 2 years) will encompass the following elements: ambulatory detection and decontamination of MRSA and MSSA prior to elective surgery combined with a structured follow-up care. Patients from the control group will be screened in the hospital setting, in accordance with the standard operating procedure (SOP) in routine care. The primary endpoint is the reduction of MRSA and MSSA colonization upon hospital admission. Secondary endpoints are complication rate (SSI), length of stay, recolonization of patients (3 and 6 months after release), patient and provider satisfaction, patient compliance and cost development.

Discussion: In case of positive results, the chance of a widespread uptake and implementation in routine care are considered high. The active involvement of primary care providers in the implementation of screening and decontamination as well as follow-up care is a unique feature of this study. The positive resonance of primary care providers during the recruitment phase highlights the relevance of the topic to the participating actors. These efforts are coupled with patient education and specifically trained medical staff, promising a sustained impact. The STAUfrei care pathway can homogenize current practices in routine care and provide a template for further intersectoral cooperation.

Trial registration: German Clinical Trials Register (DRKS), DRKS00016615. Registered on April 1st, 2019.

Keywords: Decontamination; Intersectoral care; MRSA; MSSA; Prevention; Staphylococcus aureus; Surgical site infection.

Publication types

  • Clinical Trial Protocol

MeSH terms

  • Controlled Clinical Trials as Topic
  • Cross Infection / prevention & control*
  • Decontamination / methods
  • Elective Surgical Procedures / adverse effects*
  • Germany
  • Humans
  • Infection Control / methods*
  • Mass Screening
  • Methicillin-Resistant Staphylococcus aureus / isolation & purification
  • Monitoring, Ambulatory
  • Staphylococcal Infections / prevention & control*
  • Staphylococcus aureus / drug effects
  • Staphylococcus aureus / isolation & purification
  • Surgical Wound Infection / microbiology
  • Surgical Wound Infection / prevention & control